These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 28212922)

  • 61. The assessment of serum-mediated phagocytosis of necrotic material by polymorphonuclear leukocytes to diagnose and predict the clinical features of systemic lupus erythematosus: an observational longitudinal study.
    Compagno M; Gullstrand B; Jacobsen S; Eilertsen GØ; Nilsson JÅ; Lood C; Jönsen A; Truedsson L; Sturfelt G; Bengtsson AA
    Arthritis Res Ther; 2016 Feb; 18():44. PubMed ID: 26860519
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE.
    Dooley MA; Houssiau F; Aranow C; D'Cruz DP; Askanase A; Roth DA; Zhong ZJ; Cooper S; Freimuth WW; Ginzler EM;
    Lupus; 2013 Jan; 22(1):63-72. PubMed ID: 23263865
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Systemic lupus erythematosus and ocular involvement: an overview.
    Dammacco R
    Clin Exp Med; 2018 May; 18(2):135-149. PubMed ID: 29243035
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
    Mahmoud RA; El-Gendi HI; Ahmed HH
    Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Diagnosis, Monitoring, and Treatment of Systemic Lupus Erythematosus: A Systematic Review of Clinical Practice Guidelines.
    Tunnicliffe DJ; Singh-Grewal D; Kim S; Craig JC; Tong A
    Arthritis Care Res (Hoboken); 2015 Oct; 67(10):1440-52. PubMed ID: 25778500
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Anti-dsDNA, anti-nucleosome and anti-C1q antibodies as disease activity markers in patients with systemic lupus erythematosus.
    Zivković V; Stanković A; Cvetković T; Mitić B; Kostić S; Nedović J; Stamenković B
    Srp Arh Celok Lek; 2014; 142(7-8):431-6. PubMed ID: 25233687
    [TBL] [Abstract][Full Text] [Related]  

  • 67. International survey on the management of patients with SLE. I. General data on the participating centers and the results of a questionnaire regarding mucocutaneous involvement.
    Vitali C; Doria A; Tincani A; Fabbri P; Balestrieri G; Galeazzi M; Meroni PL; Migliorini P; Neri R; Tavoni A; Bombardieri S
    Clin Exp Rheumatol; 1996; 14 Suppl 16():S17-22. PubMed ID: 9049449
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome].
    Ampélas JF; Wattiaux MJ; Van Amerongen AP
    Encephale; 2001; 27(6):588-99. PubMed ID: 11865567
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Serum cystatin C is independently associated with renal impairment and high sensitivity C-reactive protein in systemic lupus erythematosus.
    Chew C; Pemberton PW; Husain AA; Haque S; Bruce IN
    Clin Exp Rheumatol; 2013; 31(2):251-5. PubMed ID: 23306163
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comparison and evaluation of lupus nephritis response criteria in lupus activity indices and clinical trials.
    Corapi KM; Dooley MA; Pendergraft WF
    Arthritis Res Ther; 2015 Apr; 17(1):110. PubMed ID: 25927414
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The Diagnosis and Treatment of Systemic Lupus Erythematosus.
    Kuhn A; Bonsmann G; Anders HJ; Herzer P; Tenbrock K; Schneider M
    Dtsch Arztebl Int; 2015 Jun; 112(25):423-32. PubMed ID: 26179016
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pathogenesis of SLE Nephritis in the Era of Precision Medicine.
    Regunathan-Shenk R; Radhakrishnan J
    Curr Rheumatol Rev; 2018; 14(2):140-144. PubMed ID: 27426406
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Diagnostic criteria for systemic lupus erythematosus: a critical review.
    Yu C; Gershwin ME; Chang C
    J Autoimmun; 2014; 48-49():10-3. PubMed ID: 24461385
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The Systemic Lupus Erythematosus Responder Index (SRI); a new SLE disease activity assessment.
    Luijten KM; Tekstra J; Bijlsma JW; Bijl M
    Autoimmun Rev; 2012 Mar; 11(5):326-9. PubMed ID: 21958603
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Systemic Lupus Erythematosus.
    Kiriakidou M; Ching CL
    Ann Intern Med; 2020 Jun; 172(11):ITC81-ITC96. PubMed ID: 32479157
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Artificial intelligence and high-dimensional technologies in the theragnosis of systemic lupus erythematosus.
    Yaung KN; Yeo JG; Kumar P; Wasser M; Chew M; Ravelli A; Law AHN; Arkachaisri T; Martini A; Pisetsky DS; Albani S
    Lancet Rheumatol; 2023 Mar; 5(3):e151-e165. PubMed ID: 38251610
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Biomarkers in systemic lupus erythematosus: challenges and prospects for the future.
    Liu CC; Kao AH; Manzi S; Ahearn JM
    Ther Adv Musculoskelet Dis; 2013 Aug; 5(4):210-33. PubMed ID: 23904865
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Non-invasive biomarkers for systemic lupus erythematosus: A lookback at 2016.
    Qin L; Mohan C
    Int J Rheum Dis; 2016 Dec; 19(12):1209-1215. PubMed ID: 28371439
    [No Abstract]   [Full Text] [Related]  

  • 79. Clinical Application of a Modular Genomics Technique in Systemic Lupus Erythematosus: Progress towards Precision Medicine.
    Zollars E; Courtney SM; Wolf BJ; Allaire N; Ranger A; Hardiman G; Petri M
    Int J Genomics; 2016; 2016():7862962. PubMed ID: 27656648
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Neurotrophic factors in systemic lupus erythematosus: markers of disease activity.
    Dias AFMP; Lanna CCD; Teixeira AL; Ferreira GA
    Clin Exp Rheumatol; 2021; 39(6):1451-1452. PubMed ID: 34128803
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.